Susquehanna International Group
ORTX

Susquehanna International Group’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Susquehanna International Group’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-16,400
Closed -$127K – 13583
2023
Q3 		$127K Buy
+16,400
New +$88.8K ﹤0.01% 10718
2021
Q2 		– Sell
-1,050
Closed -$76K – 13450
2021
Q1 		$76K Buy
+1,050
New +$74.6K ﹤0.01% 11950
2020
Q4 		– Sell
-1,470
Closed -$60K – 11897
2020
Q3 		$60K Buy
+1,470
New +$76K ﹤0.01% 10152

Susquehanna International Group's ORTX Position: Q1 2024 in Review

Susquehanna International Group sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 34,028 shares — an estimated $560K sold.

Susquehanna International Group first reported a position in ORTX in Q3 2020 and held it in 8 quarters. The position peaked at $1.17M in Q1 2021. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

  • Susquehanna International Group reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 34,028 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $560K.
  • Susquehanna International Group first reported a position in Orchard Therapeutics plc American Depositary Shares in Q3 2020 and held it in 8 quarters.
  • Susquehanna International Group's Orchard Therapeutics plc American Depositary Shares position peaked at $1.17M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.